Intuitive Surgical (ISRG), as an outstanding growth stock, has demonstrated remarkable performance in the past and holds promising prospects for the future. Over the past decade, the company’s stock price has achieved an average annual growth rate of 23%, and this figure has risen to nearly 30% in the last three years. Had an investor invested $10,000 ten years ago, its value would have grown to approximately $80,610 today. In comparison, the average return of the S&P 500 index during the same period was 13.6%, and the same investment would have only increased to $33,720—though this performance is still considered solid.
Intuitive Surgical is a leading company in the field of robotic surgical equipment. Its da Vinci Surgical System has been installed in more than 9,900 units across 72 countries worldwide and has cumulatively assisted in over 16 million surgeries. The company’s business model is equally attractive, with 84% of its revenue not coming from the sale of expensive surgical systems but from ongoing and stable services, consumables, and accessories—once hospitals adopt the da Vinci system, they become reliant on Intuitive for continued support.
As the global population continues to age, the demand for robot-assisted surgeries in areas such as colorectal, cardiac, hernia, and pulmonary procedures is expected to grow steadily, providing a solid foundation for the company’s long-term development. Although, by certain valuation metrics, Intuitive Surgical’s stock is not cheap—for instance, its recent forward price-to-earnings ratio stands at 51—it remains below its five-year average of 56. The recent pullback in the stock price also offers a more attractive entry point for long-term investors.
Wall Street analysts are generally optimistic about the stock, with an average broker rating (ABR) of 1.76, falling between “Strong Buy” and “Buy.” Among the 29 institutions that contribute to this rating, 18 have given a “Strong Buy” recommendation, while two have given a “Buy,” together accounting for nearly 70% of the total. However, it is worth noting that relying solely on analyst recommendations to make investment decisions is often insufficient. Multiple studies have shown that brokerage ratings have limited effectiveness in helping investors identify stocks with genuine upside potential.
